| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/25/2002 | WO2002032431A1 Compositions for external preparations |
| 04/25/2002 | WO2002032430A1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002032377A2 Estrogen receptor modulators |
| 04/25/2002 | WO2002032373A2 Estrogen receptor modulators |
| 04/25/2002 | WO2002032234A1 Anti-stress composition designed to be mainly incorporated in nutritional carriers |
| 04/25/2002 | WO2001083740A3 Splice-region antisense composition and method |
| 04/25/2002 | WO2001076574A3 Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists |
| 04/25/2002 | US20020049326 Benzosulfones and related compositions and methods |
| 04/25/2002 | US20020049233 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049196 Hexahydro-pyrazolo-(4,3-c)pyridine derivatives useful for increasing the endogenous production or release of growth hormone in a human or other animal, thus treat or prevent osteoporosis |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425174A1 Human gene critical to fertility |
| 04/25/2002 | CA2424729A1 Estrogen receptor modulators |
| 04/25/2002 | CA2424726A1 Estrogen receptor modulators |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2419388A1 Substituted dipeptides as growth hormone secretagogues |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1198995A1 Anti-stress composition for incorporation in nutritional carriers |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198477A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198231A1 Bicyclic antagonists selective for the(alpha)v(beta)3 integrin |
| 04/24/2002 | EP1156787A4 Oxadiazole compounds and compositions for delivering active agents |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/24/2002 | CN1346274A Formulation comprising testosteron undecanoate and castor oil |
| 04/24/2002 | CN1346269A Calcilytic compounds |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376495 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 04/23/2002 | US6376476 Isoprenoid pathway inhibitors for stimulating bone growth |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/18/2002 | WO2002031514A2 A method of determining the initial dose of vitamin d compounds |
| 04/18/2002 | WO2002031146A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | WO2002031145A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | WO2002030924A1 Quinazoline derivatives with anti-tumour activity |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030876A2 Cyclic carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030407A1 ESTROGEN RECEPTOR-β LIGANDS |
| 04/18/2002 | WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 04/18/2002 | WO2002030184A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal |
| 04/18/2002 | WO2001087265A3 Pharmaceutical form of administration for peptides, methods for its production and use |
| 04/18/2002 | WO2001077177A8 Gpcr-proteins and nucleic acids encoding same |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001068075A3 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | US20020045774 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 04/18/2002 | US20020045638 Method of treating estrogen receptor positive carcinoma |
| 04/18/2002 | US20020045623 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 04/18/2002 | US20020045622 Growth hormone secretagogues |
| 04/18/2002 | US20020045595 N6 heterocyclic 8-modified adenosine derivatives |
| 04/18/2002 | US20020045572 Method of treating the syndrome of type 2 diabetes in humans |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020044964 Deliver of testosterone to the bloodstream of a mammal through a mucosal surface with polycarbophil and carbopol polymers |
| 04/18/2002 | DE10049736A1 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 17alpha-Fluoroalkyl steroids, processes for their preparation and pharmaceutical compositions containing them |
| 04/18/2002 | DE10048634A1 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring 19-Nor-17alpha-pregna-1,3,5 (10) triene-17beta-ols with a 21, 16alpha-lactone |
| 04/18/2002 | CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425610A1 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | CA2425194A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal |
| 04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
| 04/18/2002 | CA2423316A1 A method of determining the initial dose of vitamin d compounds |
| 04/17/2002 | EP1197496A1 Novel peptides |
| 04/17/2002 | EP1197208A1 Sustained release compositions, process for producing the same and use thereof |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196444A1 Peptides that lower blood glucose levels |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196438A1 A ligand of the protein "beacon" |
| 04/17/2002 | EP1196428A1 11$g(b)-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 04/17/2002 | EP1196416A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 04/17/2002 | EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 04/17/2002 | EP1196381A2 Process for the preparation of n-(1,1-dimethylethyl)-4-((5'-ethoxy-4-cis-(2-(4-morfolino)ethoxy)-2'-oxospiro(cyclohexan-1,3'-(3h)indol)-1'(2'h)-yl)-sulfonyl)-3-methoxybenzamide and its salts |
| 04/17/2002 | EP1196148A1 Process for microencapsulation of water soluble substances |
| 04/17/2002 | EP0970103B1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 04/17/2002 | EP0937038B1 Vitamin d analogues |
| 04/17/2002 | EP0934290B1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/17/2002 | EP0906127B1 Novel devices for transdermal administering of trimegestone |
| 04/17/2002 | CN1345335A Melanocortin receptor ligands |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
| 04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372711 Receptor binding assay using polypeptide have contiguous sequence of extracellular domain or polypeptide mutein genetically engineered by insertion, deletion, or replacement |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |